Missed opportunities in the secondary prevention of myocardial infarction: An assessment of the effects of statin underprescribing on mortality
To access this article, please choose from the options below
The Institute for Clinical Evaluative Sciences is supported in part by a grant from the Ontario Ministry of Health and Long-term Care. The opinions, results, and conclusions are those of the authors and no endorsement by the Ministry of Health and Long-term Care or by the Institute for Clinical Evaluative Sciences is intended or should be inferred. This research was supported in part by operating grants from the Canadian Institutes of Health Research (CIHR) and the Heart and Stroke Foundation to the Canadian Cardiovascular Outcomes Research Team. Drs Austin, Mamdani, and Juurlink are supported by New Investigator awards from the CIHR. Dr Juurlink is also supported by the University of Toronto Drug Safety Research Group. Dr Alter is supported by a New Investigator award from the CIHR and the Heart and Stroke Foundation. Dr Tu is supported by a Canada Research Chair in Health Services Research.
PII: S0002-8703(05)00651-4
doi:10.1016/j.ahj.2005.06.034
© 2006 Mosby, Inc. All rights reserved.
